4.8 Review

Nuclear Receptors in Liver Disease

Journal

HEPATOLOGY
Volume 53, Issue 3, Pages 1023-1034

Publisher

WILEY
DOI: 10.1002/hep.24148

Keywords

-

Funding

  1. Austrian Science Foundation [P18613-B05, F3008-B05]
  2. European Community [HEALTH-F2-2009-241762]
  3. Intercept
  4. Austrian Science Fund (FWF) [F 3008] Funding Source: researchfish

Ask authors/readers for more resources

Nuclear receptors are ligand-activated transcriptional regulators of several key aspects of hepatic physiology and pathophysiology. As such, nuclear receptors control a large variety of metabolic processes including hepatic lipid metabolism, drug disposition, bile acid homeostasis, as well as liver regeneration, inflammation, fibrosis, cell differentiation, and tumor formation. Derangements of nuclear receptor regulation and genetic variants may contribute to the pathogenesis and progression of liver diseases. This places nuclear receptors into the frontline for novel therapeutic approaches for a broad range of hepatic disorders and diseases including cholestatic and fatty liver disease, drug hepatotoxicity, viral hepatitis, liver fibrosis, and cancer. (HEPATOLOGY 2011;53:1023-1034)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available